Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

The pathway of cross-presentation is influenced by the particle size of phagocytosed antigen.

Mant A, Chinnery F, Elliott T, Williams AP.

Immunology. 2012 Jun;136(2):163-75. doi: 10.1111/j.1365-2567.2012.03558.x.

2.

The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells.

Tran KK, Shen H.

Biomaterials. 2009 Mar;30(7):1356-62. doi: 10.1016/j.biomaterials.2008.11.034. Epub 2008 Dec 16.

3.

Cross-presentation of phage particle antigen in MHC class II and endoplasmic reticulum marker-positive compartments.

Wan Y, Wu Y, Zhou J, Zou L, Liang Y, Zhao J, Jia Z, Engberg J, Bian J, Zhou W.

Eur J Immunol. 2005 Jul;35(7):2041-50.

4.

A proteasome-dependent, TAP-independent pathway for cross-presentation of phagocytosed antigen.

Merzougui N, Kratzer R, Saveanu L, van Endert P.

EMBO Rep. 2011 Dec 1;12(12):1257-64. doi: 10.1038/embor.2011.203.

5.

Receptor-mediated phagocytosis elicits cross-presentation in nonprofessional antigen-presenting cells.

Giodini A, Rahner C, Cresswell P.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3324-9. doi: 10.1073/pnas.0813305106. Epub 2009 Feb 13.

7.
8.

Cross-presentation: underlying mechanisms and role in immune surveillance.

Rock KL, Shen L.

Immunol Rev. 2005 Oct;207:166-83. Review.

PMID:
16181335
9.

Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles.

Shen H, Ackerman AL, Cody V, Giodini A, Hinson ER, Cresswell P, Edelson RL, Saltzman WM, Hanlon DJ.

Immunology. 2006 Jan;117(1):78-88.

10.

Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway.

Win SJ, Ward VK, Dunbar PR, Young SL, Baird MA.

Immunol Cell Biol. 2011 Aug;89(6):681-8. doi: 10.1038/icb.2010.161. Epub 2011 Jan 11.

PMID:
21221122
11.

Targeting to static endosome is required for efficient cross-presentation of endoplasmic reticulum-resident oxygen-regulated protein 150-peptide complexes.

Kutomi G, Tamura Y, Okuya K, Yamamoto T, Hirohashi Y, Kamiguchi K, Oura J, Saito K, Torigoe T, Ogawa S, Hirata K, Sato N.

J Immunol. 2009 Nov 1;183(9):5861-9. doi: 10.4049/jimmunol.0803768. Epub 2009 Oct 7.

12.

The neonatal FcR-mediated presentation of immune-complexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells.

Liu X, Lu L, Yang Z, Palaniyandi S, Zeng R, Gao LY, Mosser DM, Roopenian DC, Zhu X.

J Immunol. 2011 Apr 15;186(8):4674-86. doi: 10.4049/jimmunol.1003584. Epub 2011 Mar 14.

13.

Leishmania evades host immunity by inhibiting antigen cross-presentation through direct cleavage of the SNARE VAMP8.

Matheoud D, Moradin N, Bellemare-Pelletier A, Shio MT, Hong WJ, Olivier M, Gagnon E, Desjardins M, Descoteaux A.

Cell Host Microbe. 2013 Jul 17;14(1):15-25. doi: 10.1016/j.chom.2013.06.003.

14.

Adaptor protein-3 in dendritic cells facilitates phagosomal toll-like receptor signaling and antigen presentation to CD4(+) T cells.

Mantegazza AR, Guttentag SH, El-Benna J, Sasai M, Iwasaki A, Shen H, Laufer TM, Marks MS.

Immunity. 2012 May 25;36(5):782-94. doi: 10.1016/j.immuni.2012.02.018. Epub 2012 May 3.

15.

Recent developments in MHC-class-I-mediated antigen presentation.

Lehner PJ, Cresswell P.

Curr Opin Immunol. 2004 Feb;16(1):82-9. Review.

PMID:
14734114
16.
17.

A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells.

Segura E, Villadangos JA.

Traffic. 2011 Dec;12(12):1677-85. doi: 10.1111/j.1600-0854.2011.01254.x. Epub 2011 Aug 16. Review.

18.

Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization.

Sudowe S, Dominitzki S, Montermann E, Bros M, Grabbe S, Reske-Kunz AB.

Immunology. 2009 Sep;128(1 Suppl):e193-205. doi: 10.1111/j.1365-2567.2008.02947.x. Epub 2008 Sep 17.

19.

The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes.

Budimir N, Meijerhof T, Wilschut J, Huckriede A, de Haan A.

Vaccine. 2010 Dec 6;28(52):8280-7. doi: 10.1016/j.vaccine.2010.10.007. Epub 2010 Oct 19.

PMID:
20965298
20.

Supplemental Content

Support Center